Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$15.76 USD
+0.57 (3.75%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $15.77 +0.01 (0.06%) 5:40 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.85 |
EPS Last Quarter | -0.83 |
Last EPS Surprise | 9.78% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.72 |
Next Year | -3.78 |
EPS (TTM) | -4.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 35.00M | NA | 35.00M | 62.18M |
# of Estimates | 1 | NA | 1 | 2 |
High Estimate | 35.00M | NA | 35.00M | 85.80M |
Low Estimate | 35.00M | NA | 35.00M | 38.56M |
Year ago Sales | 0.00M | 0.00M | NA | 35.00M |
Year over Year Growth Est. | NA | NA | NA | 77.65% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.85 | -0.95 | -3.72 | -3.78 |
# of Estimates | 7 | 6 | 8 | 8 |
Most Recent Consensus | -0.94 | -0.99 | -4.06 | -4.25 |
High Estimate | -0.41 | -0.91 | -3.02 | -3.04 |
Low Estimate | -0.96 | -0.99 | -4.06 | -4.45 |
Year ago EPS | -1.07 | -1.85 | -4.47 | -3.72 |
Year over Year Growth Est. | 20.56% | 48.65% | 16.78% | -1.61% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 3 | 2 |
Up Last 60 Days | 0 | 0 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 2 | 3 | 4 |
Down Last 60 Days | 2 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.85 | -0.95 | -3.72 | -3.78 |
7 Days Ago | -0.85 | -0.95 | -3.72 | -3.78 |
30 Days Ago | -0.88 | -0.93 | -3.68 | -3.60 |
60 Days Ago | -0.91 | -0.96 | -3.81 | -3.73 |
90 Days Ago | -0.91 | -0.96 | -3.81 | -3.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.85 | -0.94 | -3.71 | -3.82 |
Zacks Consensus Estimate | -0.85 | -0.95 | -3.72 | -3.78 |
Earnings ESP | 0.00% | 0.92% | 0.19% | -1.05% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.83 | -0.79 | -1.85 | -1.07 | NA |
Estimate | -0.92 | -1.01 | -1.06 | -0.96 | NA |
Difference | 0.09 | 0.22 | -0.79 | -0.11 | -0.15 |
Surprise | 9.78% | 21.78% | -74.53% | -11.46% | -13.61% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more